Main

related bits

0

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-01-01 22:46:57

expired found date

-

created at

2024-07-07 15:09:39

updated at

2026-03-03 06:20:16

Domain name statistics

length

11

crc

14468

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

256482523

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

50628

mp size raw text

3788

mp inner links count

3

mp inner links status

20 (imported)

Open Graph

title

Travere Therapeutics

description

Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.

site name

Travere

author

updated

2026-02-27 15:00:16

raw text

Travere Therapeutics | In Rare For Life For best experience enable Javascript. Contact Us Careers Facebook Instagram LinkedIn Our Company Who We Are Leadership & Board Patient Advocacy Diversity, Equity, Inclusion & Belonging Grant Programs ISR Grants Med Ed Grants Contact Us Careers News Our Science Our Pipeline Sparsentan for FSGS Pegtibatinase Alagille Syndrome Collaboration Therapeutic Areas IgA Nephropathy (IgAN) Focal Segmental Glomerulosclerosis (FSGS) Classical Homocystinuria (HCU) Alagille Syndrome (ALGS) Cystinuria Clinical Trials Expanded Access Diagnostic Testing Programs Publications Our Therapies Rare Life Investors & Media Press Releases Events & Presentations Leadership & Board Governance Documents SEC Filings Quarterly Results Stock Information Historic Stock Lookup Analyst Coverage Investor Q&As Contact Us In Rare For Life Travere Therapeuti...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Pozostałe (16)

index version

1

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

2540

text words

435

text unique words

240

text lines

120

text sentences

11

text paragraphs

4

text words per sentence

39

text matched phrases

0

text matched dictionaries

0

RSS

rss status

32 (unknown)

rss found date

2024-01-01 22:46:57

rss size orig

23784

rss items

10

rss spam phrases

0

rss detected language

1 (English)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)

sitemap review version

2

sitemap urls count

245

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2023-12-27 02:29:42

sitemap process date

2024-11-20 12:22:46

sitemap first import date

-

sitemap last import date

2025-05-20 18:53:51